source
- FDA releases draft guidance on container closure and device components for biosimilar combination productsThe FDA issued draft guidance aimed at helping sponsors develop container closure systems and device constituents for biosimilar and interchangeable biosimilar combination products. The guidance f…
- Authors rebut mischaracterization of their 2023 Lancet Covid study in recent op-edThe authors of a 2023 Lancet analysis on the United States Covid response wrote to correct a recent First Opinion piece that they say misrepresented their work. While they welcome calls for additio…